Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7386)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2013 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i37/6278.htm |
| Number | Citing Articles |
| 1 |
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. Journal of Gastroenterology 2020; 55(5): 496 doi: 10.1007/s00535-020-01680-0
|
| 2 |
William R. Treem, Melissa Palmer, Isabelle Lonjon-Domanec, Daniel Seekins, Lara Dimick-Santos, Mark I. Avigan, John F. Marcinak, Ajit Dash, Arie Regev, Eric Maller, Meenal Patwardhan, James H. Lewis, Don C. Rockey, Adrian M. Di Bisceglie, James W. Freston, Raul J. Andrade, Naga Chalasani. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety 2021; 44(2): 133 doi: 10.1007/s40264-020-01014-2
|
| 3 |
Mingyu Li, Zheng Zong, Xinmiao Xiong, Jing Fan, Huan Zhong, Na Liu, Wei Ye, Jisheng Jing. Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy. Frontiers in Cellular and Infection Microbiology 2023; 12 doi: 10.3389/fcimb.2022.1053608
|
| 4 |
Xixia Huang, Hong Wang, Wenhong Zhang, Erli Gu. Verification of hepatitis B–related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment. European Journal of Gastroenterology & Hepatology 2022; 34(5): 546 doi: 10.1097/MEG.0000000000002302
|
| 5 |
You-Wen Tan, Yun Ye, Guo-Hong Ge, Wei Zhao, Jian-He Gan, Yun Zhao, Zhi-Lin Niu, Dong-Jun Zhang, Li Chen, Xue-Jun Yu, Li-Jun Yang. Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B. World Journal of Gastroenterology 2015; 21(7): 2089-2095 doi: 10.3748/wjg.v21.i7.2089
|
| 6 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
| 7 |
Ruma Rajbhandari, Raymond T Chung. Treatment of Hepatitis B: A Concise Review. Clinical and Translational Gastroenterology 2016; 7(9): e190 doi: 10.1038/ctg.2016.46
|
| 8 |
Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
|
| 9 |
鹰 袁. A Case Study of Professor Luo Weisheng in the Treatment of Post-Hepatitis B Cirrhosis. Traditional Chinese Medicine 2024; 13(11): 3219 doi: 10.12677/tcm.2024.1311478
|